Skip to NavigationSkip to content

Pharmafile - Medical Communications News

IBM’s team reported that phishing emails were delivered in six countries around the world under the identity of an executive at Chinese cold chain...
After 24 weeks of treatment, Phase 3 data showed that the drug generated a “significant reduction” in attacks experienced by trial participants...
Over the course of just one year, Moderna has become on of the most talked-about names in biotech, growing more than sevenfold from $19.23 at the...
Check out the five biggest COVID-19 stories of the past week.
As always, the publication features three key therapeutic areas; this edition focuses on Infectious Diseases, Rare Disease, and Respiratory.
With globally scalable solutions that meet the strictest regulatory and industry standards, Avantor Clinical Services provides you with end-to-end...
Hackers suspected to be operating from North Korea have tried to break into the systems of AstraZeneca, two people with knowledge of the event told...
This is the pair’s second successful Japanese approval for the drug, which is already available in the country for the treatment of anaemia of CKD in...
AstraZeneca is expected to launch new global trials to assess the efficacy of its COVID-19 vaccine using a lower dosage.
The European Union has fined Teva and Cephalon for colluding to keep a cheap alternative sleep disorder medicine off the market.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches